Targeting Microbiota 2020 Speakers

Targeting Microbiota 2020 Peter Konturek v3FMT 2020: Reorganization and Perspective
Peter C. Konturek, President of ISM & Teaching Hospital of the University of Jena, Germany
Targeting Microbiota 2020 Lanjuan Li Human Gut Microbes and COVID-19
Lanjuan Li, Zhejiang University, China Microbiome of IBD and the Potential of Machine Learning
Marcus Claesson, University College Cork, Ireland
Targeting Microbiota 2020 Yang Yu LiuAn Ecological Framework to Understand the Efficacy of Fecal Microbiota Transplantation
Yang-Yu Liu,
Harvard Medical School &  Brigham and Women's Hospital, USA
Targeting Microbiota 2020 Marvin EdeasConsider Microbiota and Mitochondria Dysfunction in COVID-19 Pathogenesis
Marvin Edeas, Institut Cochin, INSERM U1016, Paris Descartes University, France
Targeting Microbiota 2020 Tao ZuoMany aspects of the Gut microbiome in Patients With COVID-19
Tao Zuo,  Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong

Short Orals Accepted:

Phospholipase A2 of microbiota as a pathogenetic determinant to induce inflammatory states in ulcerative colitis
Wolfgang Stremmel, Medical Center Baden-Baden, Germany

Low abundance of lactococcus lactis in human colorectal cancer is associated with decreased natural killer cell
Xiangsheng Fu, Affiliated Hospital of North Sichuan Medical College, China

Effect of probiotics in children with infantile eczema: a double-blind randomized control trial
Tamara Sabbi, ASL RMG Palestrina, Italy

Helicobacter_bilis may play a role in the carcinogenesis of colitis-associated colon cancer correlating to increased number of CD4+CD45RB+ T Cells
Wei Peng, Affiliated Hospital of North Sichuan Medical College, China

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next